PubMed · 6781890
Sodium valproate, platelet dysfunction, and bleeding.
Abstract
The antiepileptic drug sodium valproate (VPA) can provoke a thrombocytopenia or platelet dysfunction, with or without hemorrhages. These unwanted side effects are probably infrequent or, at least, have little clinical importance except in patients undergoing surgery. Thromboelastography appears to be a reliable screening test. As hematological abnormalities are often dose related, VPA dosages greater than 40 mg/kg/day are not advised.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
P Loiseau. 1981. Sodium valproate, platelet dysfunction, and bleeding.. https://doi.org/10.1111/j.1528-1157.1981.tb04094.x. https://pubmed.health/record/pubmed%3A6781890/sodium-valproate-platelet-dysfunction-and-bleeding
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.